Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid type A receptor alpha 2 subunit (GABRA2) is a protein that forms part of the GABA-A receptor, a ligand-gated chloride channel activated by GABA, the principal inhibitory neurotransmitter in the mammalian central nervous system. Alpha-2 containing GABA-A receptors play key roles in emotional regulation, behavioral control, and mediation of anxiolytic effects. Alterations or mutations in GABRA2 have been linked to alcoholism, anxiety disorders, depression, drug dependence, and schizophrenia.
Allosteric modulation of chloride channel opening frequency and duration
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha 2 subunit (GABRA2).